MedTrace Logo

VIVO European Observational Registry

NCT04990089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2025-01-31

No results posted yet for this study

Summary

A multi-center, observational registry conducted in Europe and the UK to prospectively review VIVO in a clinical setting in 125 patients.

Conditions

  • Ventricular Arrythmia
  • Ventricular Tachycardia
  • Premature Ventricular Contraction

Interventions

DEVICE

VIVO

VIVO is a per-procedural planning tool designed to non-invasively identify the origin of a ventricular arrhythmia.

Sponsors & Collaborators

  • Catheter Precision. Inc.

    lead INDUSTRY

Principal Investigators

  • Andre Ng, MD · Glenfield University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2024-06-28
Completion
2024-09-28
FDA Device
Yes

Countries

  • Ireland
  • Italy
  • Netherlands
  • Portugal
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04990089 on ClinicalTrials.gov